Teligent EBITDA Margin 2010-2021 | TLGT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Teligent (TLGT) over the last 10 years. The current EBITDA margin for Teligent as of June 30, 2021 is .
| Teligent EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2021-06-30 |
$0.05B |
$-0.13B |
-280.43% |
| 2021-03-31 |
$0.05B |
$-0.12B |
-240.00% |
| 2020-12-31 |
$0.05B |
$-0.13B |
-282.22% |
| 2020-09-30 |
$0.05B |
$-0.02B |
-47.06% |
| 2020-06-30 |
$0.06B |
$-0.02B |
-29.09% |
| 2020-03-31 |
$0.06B |
$-0.01B |
-18.64% |
| 2019-12-31 |
$0.07B |
$0.00B |
6.15% |
| 2019-09-30 |
$0.07B |
$0.01B |
7.58% |
| 2019-06-30 |
$0.07B |
$0.00B |
6.06% |
| 2019-03-31 |
$0.06B |
$-0.00B |
-1.56% |
| 2018-12-31 |
$0.07B |
$-0.00B |
-1.52% |
| 2018-09-30 |
$0.06B |
$-0.00B |
-3.33% |
| 2018-06-30 |
$0.05B |
$-0.01B |
-15.09% |
| 2018-03-31 |
$0.06B |
$-0.00B |
-5.45% |
| 2017-12-31 |
$0.06B |
$0.00B |
5.00% |
| 2017-09-30 |
$0.06B |
$0.01B |
14.29% |
| 2017-06-30 |
$0.07B |
$0.02B |
23.53% |
| 2017-03-31 |
$0.07B |
$0.02B |
23.88% |
| 2016-12-31 |
$0.06B |
$0.01B |
22.22% |
| 2016-09-30 |
$0.06B |
$0.01B |
17.74% |
| 2016-06-30 |
$0.06B |
$0.01B |
17.24% |
| 2016-03-31 |
$0.05B |
$0.01B |
12.00% |
| 2015-12-31 |
$0.05B |
$0.01B |
11.11% |
| 2015-09-30 |
$0.05B |
$0.01B |
21.74% |
| 2015-06-30 |
$0.04B |
$0.01B |
19.51% |
| 2015-03-31 |
$0.04B |
$0.01B |
21.05% |
| 2014-12-31 |
$0.03B |
$0.01B |
14.71% |
| 2014-09-30 |
$0.03B |
$0.00B |
3.70% |
| 2014-06-30 |
$0.02B |
$0.00B |
4.17% |
| 2014-03-31 |
$0.02B |
$0.00B |
4.55% |
| 2013-12-31 |
$0.02B |
$0.00B |
5.26% |
| 2013-09-30 |
$0.01B |
$-0.00B |
-7.14% |
| 2013-06-30 |
$0.01B |
$-0.00B |
-8.33% |
| 2013-03-31 |
$0.01B |
$-0.00B |
-10.00% |
| 2012-12-31 |
$0.01B |
$-0.00B |
-25.00% |
| 2012-09-30 |
$0.01B |
$-0.00B |
-25.00% |
| 2012-06-30 |
$0.01B |
$-0.00B |
-25.00% |
| 2012-03-31 |
$0.01B |
$-0.00B |
-37.50% |
| 2011-12-31 |
$0.01B |
$-0.00B |
-37.50% |
| 2011-09-30 |
$0.01B |
$-0.00B |
-37.50% |
| 2011-06-30 |
$0.01B |
$-0.00B |
-50.00% |
| 2011-03-31 |
$0.01B |
$-0.00B |
-50.00% |
| 2010-12-31 |
$0.01B |
$-0.00B |
-57.14% |
| 2010-09-30 |
$0.01B |
$-0.00B |
-66.67% |
| 2010-06-30 |
$0.01B |
$-0.00B |
-80.00% |
| 2010-03-31 |
$0.00B |
$-0.00B |
-75.00% |
| 2009-12-31 |
$0.00B |
$-0.00B |
-75.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
